HP-MR |
hyperpolarized magnetic resonance |
MRI |
Magnetic resonance imaging |
MR |
Magnetic resonance |
MRS |
Magnetic resonance spectroscopy |
NMR |
Nuclear magnetic resonance |
DNP |
Dynamic nuclear polarization |
PHIP |
Parahydrogen induced polarization |
SABRE |
Signal amplification by reversible exchange |
TRAMP |
Transgenic mouse prostate cancer model |
PDX |
Patient derived xenograft |
AML |
Acute myeloid leukemia |
LDH |
Lactate dehydrogenase |
NADH |
Nicotinamide adenine dinucleotide |
GLUT5 |
Glucose transporter type-5 |
ALT |
Alanine transaminase |
GLS |
Glutaminase |
IDH |
Isocitrate dehydrogenases |
BCAT |
Branched-chain aminotransferases |
PET |
Positron emission tomography |
FDG |
Fluoro-deoxy-glucose |
BPTES |
Bis-2-(5-phenylacetamido-1,2,4-diathiazol-2-yl) ethyl sulfide |
DIDS |
4,4’-diisothiocyanostilbene-2,2’-disulfonic acid |
HIF |
Hypoxia-inducible factor |
PSA |
Prostate-specific antigen |
HIFU |
High-intensity focused ultrasound |
kPL
|
Apparent rate constant |
lac/pyr |
Lactate-to-Pyruvate ratio |
CTLA4 |
Cytotoxic T-lymphocyte-associated antigen 4 |
PD-L1 |
Programmed death-ligand 1 |
PD1 |
Programmed death 1 |